AJ Hospital implements innovative BVS device to treat blocked arteries

AJ Hospital implements innovative BVS device to treat blocked arteries

Mangalore Today News Network

Mangalore, October 23, 2013: AJ Hospital implements Bioresorbable Vascular Scaffold (BVS), an innovative device designed to treat patients with blocked arteries.

Speaking at the press meet held at AJ Hospital on October 23, Wednesday, Dr Prashanth Marla said that a 29 year old Rakesh Shetty(Name Changed) recently married,  is a smoker with no previous history of heart condition. He was wheeled into emergency at A.J.Hospital and Research Centre when he complained of uneasiness and chest pain.  He was immediately taken to Cathlab when doctors confirmed he had a heart attack and needed immediate surgery. Doctors decided to implant novel treatment for clogged arteries – Bioresorbable Vascular Scaffold (BVS).  Patient was discharged the next day and feels healthier today.

BVS is a groundbreaking device designed to restore blood flow by opening a clogged vessel and providing support while it heals. Once the vessel can remain open without the extra support, the bioresorbable scaffold is designed to be slowly metabolized and eventually dissolves into carbon dioxide and water in the body.

"Treatments for coronary artery disease have come a long way from the days of balloon angioplasties and metal stents. However, a dissolving stent like BVS is interesting as the clogged artery can be enlarged and supported effectively without the stent leaving any fragments behind in the blood stream." Explained Interventional Cardiologist, A.J.Hospital and Research Centre, Dr. B.V.Manjunath.”

For the first time in India, insurance is being provided to the patient with BVS. Insurance covers against the risk of re-do procedure: Percutaneous Transluminal Coronary Angioplasty(PTCA), Coronary Artery Bypass Graft (CABG)and Plain Old Balloon Angioplasty(POBA) in a patient where BVS is deployed. The sum assured per scaffold is 2 lakh which will cover hospitalization expenses. The cover is valid for 2 years from the date of implant.

, Dr. R. Purushotham, Interventional Cardiologist at A.J.Hospital and Research Centre said that “The device is made of polylactide, a proven biocompatible material that is commonly used in medical implants such as dissolving sutures. Since a permanent implant is not left behind, a vessel treated with a BVS ultimately may have the ability to move, flex and pulsate similar to an untreated vessel. The potential to restore these naturally occurring vessel functions, or vascular restoration, is one of the features that will make BVS unique in the treatment of coronary artery disease.”

Cardiovascular  disease  remains  the  leading  cause  of death  globally  and By  2030,  almost  23.6  million  people  will  die  from cardiovascular disease every year. The largest increase in number of deaths will occur in the South- East Asia Region. 

The average age of people with heart ailments is coming down. We are getting patients as young as 25 confirm Dr. B.V.Manjunath and Dr. R. Purushotham.  With an ever-increasing number of young Indians suffering from heart diseases, a drastic change in lifestyle and eating habits is the need of the hour to tackle the alarming situation. Many of the young professionals today have odd working hours that leads to stress, and not many of them have the privilege of savouring home cooked meals. On top of it, the indulgence in smoking and drinking to “reduce the stress” worsens the situation. Such a lifestyle results in high blood pressure, obesity, diabetes, etc. leading to heart ailments.

About BVS (Bioresorbable Vascular Scaffold):

BVS is a first-of-its-kind device for the treatment of coronary artery disease (CAD). It works by restoring blood flow to the heart similar to a metallic stent, but then dissolves into the body, leaving behind a treated vessel that may resume more natural function and movement because it is free of a permanent metallic stent. The potential long-term benefits of a scaffold that dissolves are significant. The vessel may expand and contract as needed to increase the flow of blood to the heart in response to normal activities such as exercising; treatment and diagnostic options are broadened; the need for long-term treatment with anti-clotting medications may be reduced; and future interventions would be unobstructed by a permanent implant.